ASBPW
Aspire Biopharma Warrant
ASBPW
ASBPW
36 hedge funds and large institutions have $2.94M invested in Aspire Biopharma Warrant in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
Holders
36
Holding in Top 10
–
Calls
$2.09M
Puts
–
Top Buyers
| 1 | +$140K | |
| 2 | +$72.9K | |
| 3 | +$26K | |
| 4 |
CS
Clear Street
New York
|
+$14.5K |
| 5 |
ACM
Atalaya Capital Management
New York
|
+$9K |
Top Sellers
| 1 | -$161K | |
| 2 | -$17K | |
| 3 | -$12K | |
| 4 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
-$8K |
| 5 |
PCM
Prelude Capital Management
New York
|
-$4K |